|

Evaluation Study of Medical-Social Collaboration Model for Middle-aged and Older Adults With Depressive Symptoms

RECRUITINGN/ASponsored by The University of Hong Kong
Actively Recruiting
PhaseN/A
SponsorThe University of Hong Kong
Started2025-06-20
Est. completion2027-06
Eligibility
Age45 Years+
Healthy vol.Accepted

Summary

The goal of this clinical trial is to learn if a medical-social collaboration model works to reduce depressive symptoms in middle-aged and older adults with depressive symptoms who are waiting for their first psychiatric appointment. Secondary outcomes of the study include reduced anxiety symptoms, reduced loneliness, reduced rumination, reduced self-criticism, improved self-reassurance, improved resilience, improved self-efficacy, improved health-related quality of life, as well as improved quality-adjusted life years, and reduced healthcare service utilisation. Researchers will compare a medical-social collaboration model to a self-management booklet. Participants will: * Receive CBT-based stepped-care interventions through the medical-social collaboration model or a self-management booklet. * Complete a survey about their mental health and service use every three months until their first psychiatric appointment.

Eligibility

Age: 45 Years+Healthy volunteers accepted
Inclusion Criteria:

* Currently awaiting psychiatric services provided by the Hospital Authority
* Have depressive symptoms of at least mild severity
* Able to provide informed consent

Exclusion Criteria:

* A known history of autism spectrum disorder, intellectual disability, schizophrenia-spectrum disorder, bipolar disorder, Parkinson's disease, or dementia
* Imminent suicidal risk (temporary exclusion)
* Communication difficulties that preclude participation

Conditions1

Depression

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.